Trials / Completed
CompletedNCT03210883
Global Electrical Heterogeneity and Clinical Outcomes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,471 (actual)
- Sponsor
- Larisa Tereshchenko · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective multicenter cohort will validate an independent association of electrocardiographic (ECG) global electrical heterogeneity (GEH) measures with sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD, and will validate and re-calibrate GEH ECG risk score for prediction of sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD.
Conditions
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2021-07-05
- Completion
- 2021-07-05
- First posted
- 2017-07-07
- Last updated
- 2021-07-08
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03210883. Inclusion in this directory is not an endorsement.